// App-Quantinova.ai

PD3-8 : Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients

Researchers

Presenter

  • Bidard F-C

Principal Investigators

  • Madic J

  • Kiialainen A

  • Giroud N

  • Schmucki R

  • Horn C

  • Spleiss O

  • Lantz O

  • Stern M-H

  • Weisser M

  • Lebofsky R

  • Pierga J-YBirzele FRamey G

  • Leroy Q

  • Rio Frio T

  • Raynal V

  • Bernard V

  • Lermine A

  • Clausen I

Medical Centers

  • Institut Curie, Paris Cedex, France

  • Roche Pharma Research and Early Development (pRED), Penzberg, GermanyInstitut Roche de Recherche et Medecine Translationnelle, Boulogne-Billancourt, FranceRoche Pharma Research and Early Development (pRED), Basel, Switzerland

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Lactate dehydrogenase

  • Tumor protein p53

  • ZFP36 Ring Finger Protein Like 1

  • Circulating DNA

  • Mutant allele fractions

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved